Pill Identifier App

Having trouble identifying pills? Try the Pill Identifier

Quickly identify pills, tablets and capsules using the web's most comprehensive Pill Identification Wizard.

Get Started

Worried about drug interactions? Use the Interactions Checker

The drug interactions tool allows you to check for drug-drug and drug-food interactions.

Check Now

Discover treatment options with the new Symptom Checker

This interactive decision guide helps identify the underlying cause of common symptoms.

Get Started

Custom search for Medical Transcriptionists?

Use our custom wildcard and phonetic search to assist in identifying drugs where the exact spelling is unknown and only the pronunciation is available.

Get Started

Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.

Posted today in New Drug Approvals

FDA Approves New Crushing Option for the Administration of Brilinta

AstraZeneca (NYSE: AZN) today announced that the US Food and Drug Administration (FDA) has approved a new administration option for acute coronary syndrome (ACS) patients who are unable to swallow Brilinta 90 mg tablets whole. Unlike other P2Y12 inhibitors, Brilinta has FDA approval to be crushed and administered in water by swallowing or via nasogastric...

Posted today in Medical

Gestational Diabetes Drug Might Raise Babies' Complication Risk

When used to treat diabetes that develops during pregnancy (gestational diabetes), the drug glyburide has been linked to a number of complications in the baby, according to a new study. In fact, infants born to mothers given glyburide (DiaBeta) during pregnancy had a higher risk of respiratory distress, needing intensive care, having low blood sugar,...

Posted today in Medical

Breast Cancer Is Not One Disease, Experts Say

Breast cancer isn't the same for every woman, even at the cellular level, according to a new statement from four major medical groups focused on the disease. The report was issued Monday by the American Cancer Society, the U.S. Centers for Disease Control and Prevention, the U.S. National Cancer Institute, and the North American Association of Central...

Posted today in New Drug Approvals

FDA Approves Jadenu (deferasirox) Tablets for Chronic Iron Overload

EAST HANOVER, N.J., March 30, 2015 Novartis announced today that the US Food and Drug Administration (FDA) has approved Jadenu (deferasirox) tablets, a new oral formulation of Exjade (deferasirox) tablets for oral suspension, for the treatment of chronic iron overload due to blood transfusions in patients 2 years of age and older, and chronic iron...

Posted today in Medical

U.S. Kids Getting Fewer Daily Calories From Fast Food

American children are getting fewer calories a day from fast food restaurants, but one-third still eat ready-to-go pizza, chicken and burgers on a daily basis, a new study finds. Among kids aged 4 to 19, national health and nutrition surveys showed that average daily calorie consumption from fast food restaurants fell by 110 calories between 2003 and...

Posted today in Medical

Lots of Leafy Greens Might Shield Aging Brains, Study Finds

A single serving of leafy green vegetables each day may help keep dementia away, new research suggests. Researchers evaluated the eating habits and mental ability of more than 950 older adults for an average of five years. Those who consumed one or two servings of foods such as spinach, kale, mustard greens and/or collards daily experienced slower...

Posted today in Medical

Could an Apple a Day Help Keep the Pharmacist Away?

Munching each day on a McIntosh, Granny Smith or other apple might not keep the doctor at bay, but a new study finds apple eaters are less likely to need a prescription medicine. The study, funded by the U.S. National Institutes of Health, looked at data from nearly 8,400 people who took part in federal health surveys between 2007 and 2010. Of those...

Posted today in Medical

Report Shows Progress in America's War on Cancer

America is making slow but steady progress against cancer, with a continuing decline in cancer deaths, according to a new report. The overall cancer death rate fell an average 1.5 percent per year between 2002 and 2011, representing improved survival for men, women and children, the report found. The rate of new cancer cases also declined an average...

Posted today in Medical

Synthetic Pot Linked to Kidney Injury

New research suggests that synthetic marijuana, also known as K2 or Spice, might harm the kidneys. "Use and abuse of these products have been tied to acute kidney injury in patients across the country," Kerry Willis, chief scientific officer of the National Kidney Foundation, said in a news release from the foundation. "Despite being legal and marketed...

Posted today in Medical

Equal Numbers of Males, Females Are Conceived: Study

Many scientists believe human conception produces more male than female embryos, with male embryos less likely to survive. But, a new study suggests that equal numbers of males and females are conceived and female embryos are less likely to survive. "It looks like more females die during pregnancy than males," said Steven Orzack, a senior research...

Read more news...

Recently added consumer and prescribing information: Cresemba, Zarxio, Farydak, Lenvima, Ibrance, Glyxambi, Evotaz, Prezcobix, Natpara, Prestalia

Posted in Blog

Harnessing the Power of the Poliovirus as a Cancer Cure

Polio, a highly infectious and crippling disease, was certainly one of the most feared viruses in the 20th century. Each year, thousands of children were left paralyzed or crippled. Polio has been successfully eliminated in the U.S. for decades due to a widespread vaccine program. So why would a group of researchers be interested in […]

Posted in Blog

Biosimilars in 2015: What Can We Expect?

On Friday, March 6th, 2015 the FDA approved Sandoz’s Zarxio, the first official biosimilar that will be made available in the U.S. Zarxio, a recombinant granulocyte colony-stimulating factor used to boost white blood cells after cancer treatments, is the long-awaited biosimilar for filgrastim (Amgen’s Neupogen). The FDA noted in their briefs that Zarxio was “highly […]

Posted in Blog

Drugs.com Adds Mayo Clinic Disease Reference

Drugs.com is pleased to announce it has licensed select content from Mayo Clinic to provide more timely and trustworthy medical condition and disease information. The articles include detailed information about medical diseases such as allergies, back pain, depression, erectile dysfunction, and type 2 diabetes. Each article includes informative sections which may include an overview, symptoms, when […]

See more blog posts or follow us on twitter.

Hide
(web2)